CM Management
Latest statistics and disclosures from CM Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARKO, ALCO, RLGT, TGB, CLPT, and represent 23.48% of CM Management's stock portfolio.
- Added to shares of these 10 stocks: HAS, CPA, FCX, OGN, PAAS, SVC, IOVA, HRTX, CRIS, COHU.
- Started 2 new stock positions in BCDA, HAS.
- Reduced shares in these 10 stocks: KD, PFE, HRI, WBD, PRGO, RIGL, NWL, WBA, JAZZ, BRKL.
- Sold out of its positions in CADE, FHN, HRI, KRON, KD, NWL, PFE, Pieris Pharmaceuticals, PRGO.
- CM Management was a net seller of stock by $-6.7M.
- CM Management has $116M in assets under management (AUM), dropping by -10.48%.
- Central Index Key (CIK): 0001841857
Tip: Access up to 7 years of quarterly data
Positions held by CM Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for CM Management
CM Management holds 57 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arko Corp (ARKO) | 6.0 | $6.9M | +2% | 1.1M | 6.59 |
|
| Ali (ALCO) | 5.0 | $5.8M | 225k | 25.93 |
|
|
| Radiant Logistics (RLGT) | 4.5 | $5.2M | 775k | 6.70 |
|
|
| Taseko Cad (TGB) | 4.1 | $4.8M | 2.5M | 1.94 |
|
|
| Clearpoint Neuro (CLPT) | 3.9 | $4.5M | -3% | 290k | 15.38 |
|
| Amicus Therapeutics (FOLD) | 3.7 | $4.2M | 450k | 9.42 |
|
|
| Royalty Pharma Com - Class A (RPRX) | 3.5 | $4.1M | 160k | 25.51 |
|
|
| Rigel Pharmaceuticals (RIGL) | 3.5 | $4.1M | -16% | 243k | 16.82 |
|
| Newmark Group Com - Class A (NMRK) | 3.3 | $3.8M | 300k | 12.81 |
|
|
| Preformed Line Products Company (PLPC) | 3.0 | $3.5M | 27k | 127.79 |
|
|
| Talos Energy (TALO) | 2.9 | $3.4M | 350k | 9.71 |
|
|
| inTEST Corporation (INTT) | 2.7 | $3.1M | +4% | 365k | 8.59 |
|
| Coherus Biosciences (CHRS) | 2.4 | $2.8M | +2% | 2.1M | 1.38 |
|
| Pagerduty (PD) | 2.4 | $2.7M | 150k | 18.26 |
|
|
| Copa Holdings Sa Com - Class A (CPA) | 2.3 | $2.6M | +71% | 30k | 87.88 |
|
| Sabre (SABR) | 2.2 | $2.6M | +7% | 700k | 3.65 |
|
| Bgc Group Com - Class A (BGC) | 2.2 | $2.5M | 275k | 9.06 |
|
|
| Viatris (VTRS) | 2.2 | $2.5M | 200k | 12.45 |
|
|
| Republic Bancorp Ky Com - Class A (RBCAA) | 2.1 | $2.4M | 35k | 69.87 |
|
|
| Organon & Co (OGN) | 1.9 | $2.2M | +50% | 150k | 14.92 |
|
| Iovance Biotherapeutics (IOVA) | 1.9 | $2.2M | +20% | 300k | 7.40 |
|
| Ark Restaurants (ARKR) | 1.9 | $2.2M | 200k | 11.00 |
|
|
| Brookline Ban (BRKL) | 1.8 | $2.1M | -20% | 180k | 11.80 |
|
| Park Hotels & Resorts Inc-wi (PK) | 1.8 | $2.1M | 150k | 14.07 |
|
|
| Centerra Gold (CGAU) | 1.7 | $2.0M | 350k | 5.69 |
|
|
| First Financial Corporation (THFF) | 1.7 | $2.0M | 43k | 46.19 |
|
|
| Barrick Gold Corp (GOLD) | 1.7 | $1.9M | 125k | 15.50 |
|
|
| Freeport-mcmoran Com - Class B (FCX) | 1.6 | $1.9M | +66% | 50k | 38.08 |
|
| Cohu (COHU) | 1.6 | $1.9M | +16% | 70k | 26.70 |
|
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $1.8M | -25% | 15k | 123.15 |
|
| Evolus (EOLS) | 1.4 | $1.7M | 150k | 11.04 |
|
|
| Pan American Silver Corp Can (PAAS) | 1.4 | $1.6M | +60% | 80k | 20.22 |
|
| Xoma Corp Del (XOMA) | 1.2 | $1.4M | 55k | 26.28 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $1.3M | 70k | 18.35 |
|
|
| Walgreen Boots Alliance (WBA) | 1.0 | $1.2M | -37% | 125k | 9.33 |
|
| Service Pptys Tr Com Sh Ben Int (SVC) | 1.0 | $1.1M | +50% | 450k | 2.54 |
|
| Eledon Pharmaceuticals (ELDN) | 1.0 | $1.1M | 275k | 4.12 |
|
|
| CVS Caremark Corporation (CVS) | 1.0 | $1.1M | -28% | 25k | 44.89 |
|
| Hasbro (HAS) | 1.0 | $1.1M | NEW | 20k | 55.91 |
|
| Heron Therapeutics (HRTX) | 0.9 | $1.1M | +40% | 700k | 1.53 |
|
| AMCON Distributing (DIT) | 0.9 | $1.1M | 8.3k | 128.16 |
|
|
| Atea Pharmaceuticals (AVIR) | 0.9 | $1.0M | +11% | 300k | 3.35 |
|
| Coya Therapeutics (COYA) | 0.8 | $917k | +11% | 160k | 5.73 |
|
| Warner Bros. Discovery (WBD) | 0.6 | $740k | -60% | 70k | 10.57 |
|
| Nektar Therapeutics (NKTR) | 0.6 | $698k | 750k | 0.93 |
|
|
| Curis (CRIS) | 0.6 | $673k | +83% | 220k | 3.06 |
|
| Lantern Pharma (LTRN) | 0.6 | $638k | +8% | 200k | 3.19 |
|
| Cytosorbents (CTSO) | 0.6 | $637k | -12% | 700k | 0.91 |
|
| Os Therapies Incorporated (OSTX) | 0.4 | $471k | +120% | 110k | 4.28 |
|
| Femasys (FEMY) | 0.4 | $468k | 425k | 1.10 |
|
|
| Compass Therapeutics (CMPX) | 0.4 | $450k | 310k | 1.45 |
|
|
| Assertio Holdings (ASRT) | 0.3 | $348k | +23% | 400k | 0.87 |
|
| Battalion Oil Corp (BATL) | 0.2 | $232k | -3% | 135k | 1.72 |
|
| Elicio Therapeutics (ELTX) | 0.2 | $204k | -20% | 40k | 5.10 |
|
| Edesa Biotech (EDSA) | 0.2 | $185k | 110k | 1.68 |
|
|
| Cognition Therapeutics (CGTX) | 0.1 | $140k | -20% | 200k | 0.70 |
|
| Biocardia (BCDA) | 0.0 | $55k | NEW | 25k | 2.18 |
|
Past Filings by CM Management
SEC 13F filings are viewable for CM Management going back to 2020
- CM Management 2024 Q4 filed Feb. 7, 2025
- CM Management 2024 Q3 filed Nov. 12, 2024
- CM Management 2024 Q2 filed Aug. 1, 2024
- CM Management 2024 Q1 filed May 14, 2024
- CM Management 2023 Q4 filed Feb. 12, 2024
- CM Management 2023 Q3 filed Nov. 7, 2023
- CM Management 2023 Q2 filed Aug. 4, 2023
- CM Management 2023 Q1 filed May 8, 2023
- CM Management 2022 Q4 filed Feb. 9, 2023
- CM Management 2022 Q3 filed Nov. 4, 2022
- CM Management 2022 Q2 filed Aug. 8, 2022
- CM Management 2022 Q1 filed May 9, 2022
- CM Management 2021 Q4 filed Feb. 2, 2022
- CM Management 2021 Q3 filed Nov. 8, 2021
- CM Management 2021 Q2 filed Aug. 10, 2021
- CM Management 2021 Q1 filed May 12, 2021